Citation

Littrell KH, Littrell SH. J. Am. Psychiatr. Nurs. Assoc. 1999; 5(2).

Copyright

(Copyright © 1999, American Psychiatric Nurses Association, Publisher SAGE Publishing)

DOI

10.1177/107839039900500212

PMID

unavailable

Abstract

Research suggests that nearly half of all patients with schizophrenia concurrently abuse substances. However, despite the prevalence of substance abuse among persons with schizophrenia, the effective treatment of these comorbid conditions has eluded mental health professionals for decades. Apart from the obvious problems associated with schizophrenia and alcohol or drug abuse, schizophrenic persons who abuse substances also experience increased rates of depression, suicide, homelessness, unemployment, and illegal activity. These diverse problems necessitate interventions that address the special needs of this population. Research indicates that the use of atypical antipsychotic agents with persons who have a dual diagnosis may prove to be efficacious with treatment, overall This article reviews the current literature pertaining to the potential expanded therapeutic benefits of enhanced efficacy of atypical antipsychotic medication in association with decreased substance Assoc [1999]. © 1999, Sage Publications. All rights reserved.

Language: en